Research shows promise for treating brain and spinal cord injuries

Research shows promise for treating brain and spinal cord injuries

New research from the University of Helsinki and the Alzheimer’s Center & Research Institute in Tampa, Florida, could hold the key in treating the millions of people worldwide suffering from paralysis and brain diseases like Alzheimer’s and ALS.  The study showed a protein called KDI tri-peptide could block the harmful effects of glutamate, which is a substance present in all degenerative brain diseases and spinal cord injuries. 

Glutamate causes permanent cell death and prevents the repair of damaged nerve connections.  The researchers found KDI has the ability to protect the brain and spinal cord from cell death.  The protein also had the ability to enable re-growth.  When KDI was applied to human brain cells, various forms of glutamate function were blocked; allowing the researchers to believe it may have wide-ranging applications. 

Currently, there are no known cures for people suffering with central nervous system injuries resulting in paralysis and a range of diseases.  There are 140 million people worldwide who suffer from paralysis and brain diseases.  Human clinical trials are expected to begin as soon as next year, and researchers hope the ability to treat degenerative brain diseases and spinal cord injuries with a naturally occurring substance in the body will be one of the greatest discoveries in treating neurological conditions in recent decades. 

Find a Lawyer Now

Search for a Personal Injury lawyer in your state or province by using the forms to the right.